Table 3.
Variables | Treatment status | p value | |
---|---|---|---|
Persistent (n = 89) | Non-persistent (n = 17) | ||
Age (years) (25–75 percentile) | 69 (67–71) | 69 (68–70) | 0.634 |
Gender | < 0.001* | ||
Male | 44 (73.3) | 16 (26.7) | |
Female | 45 (97.8) | 1 (2.2) | |
Medical complications | |||
Blood and vascular | 1a | ||
Mentioned | 15 (83.3) | 3 (16.7) | |
Not mentioned | 74 (84.1) | 14 (15.9) | |
Body | 1a | ||
Mentioned | 5 (83.3) | 1 (16.7) | |
Not mentioned | 84 (84) | 16 (16) | |
Brain and heart | 0.111a | ||
Mentioned | 23 (95.8) | 1 (4.2) | |
Not mentioned | 66 (80.5) | 16 (19.5) | |
Eye | 0.186 | ||
Mentioned | 47 (88.7) | 6 (11.3) | |
Not mentioned | 42 (79.2) | 11 (20.8) | |
Foot and hand | 0.491 | ||
Mentioned | 34 (87.2) | 5 (12.8) | |
Not mentioned | 55 (82.1) | 12 (17.9) | |
Kidney, liver and other organs | 0.732a | ||
Mentioned | 17 (89.5) | 2 (10.5) | |
Not mentioned | 72 (82.8) | 15 (17.2) | |
Threat to life | 1a | ||
Mentioned | 22 (84.6) | 4 (15.4) | |
Not mentioned | 67 (83.8) | 13 (16.2) | |
Necrosis | 1a | ||
Mentioned | 14 (87.5) | 2 (12.5) | |
Not mentioned | 75 (83.3) | 15 (16.7) | |
Nerve | 0.634a | ||
Mentioned | 7 (77.8) | 2 (22.2) | |
Not mentioned | 82 (84.5) | 15 (15.5) | |
Thirsty | 0.296a | ||
Mentioned | 1 (50) | 1 (50) | |
Not mentioned | 88 (84.6) | 16 (15.4) | |
Uncertainty of the future | |||
Abstract | 0.886 | ||
Mentioned | 35 (83.3) | 7 (16.7) | |
Not mentioned | 54 (84.4) | 10 (15.6) | |
No clear answer | 0.001*,a | ||
Applicable | 2 (28.6) | 5 (71.4) | |
Not applicable | 87 (87.9) | 12 (12.1) | |
Declined social life | |||
Family | 1a | ||
Mentioned | 10 (83.3) | 2 (16.8) | |
Not mentioned | 79 (84) | 15 (16) | |
Restriction in life | 0.519a | ||
Mentioned | 18 (90) | 2 (10) | |
Not mentioned | 71 (82.6) | 15 (17.4) | |
Treatment | 0.031* | ||
Mentioned | 42 (93.3) | 3 (6.7) | |
Not mentioned | 47 (77) | 14 (23) |
Values are given as n (%), unless indicated otherwise
*Statistically significant at p < 0.05
aFisher’s exact test